...
首页> 外文期刊>Journal of drug targeting >An in-vitro evaluation of lectin cytotoxicity using cell lines derived from the ocular surface.
【24h】

An in-vitro evaluation of lectin cytotoxicity using cell lines derived from the ocular surface.

机译:使用源自眼表的细胞系对凝集素的细胞毒性进行体外评估。

获取原文
获取原文并翻译 | 示例

摘要

Lectins are proteins or glycoproteins of non-immune origin capable of binding to one or more specific sugar residues. The potential for using lectins as a means of locating and "anchoring" a drug delivery system to a target site on a mucosal surface in order to promote controlled drug delivery and enhanced absorption has been described in previous work. Toxicity is evident for many lectins, and this study has investigated the cytotoxicity of lectins to cells derived from the cornea and conjunctiva. Cultures of transformed cell lines from the conjunctiva and cornea were exposed to solution of lectins, and the viability of these cells assessed by their ability to take up an MTT stain relative to the control. Clear evidence of lectin cytotoxicity was apparent for all of the lectins tested in this study, particularly at higher concentrations and over the longer (48 h) time period. This would raise issues with their potential use in targeted drug delivery systems. The lectins from Lycopersicon esculentum and Helix pomatia appeared to show the least cytotoxic activity and so could be considered the most promising. The lectins from Solanum tuberosum and Triticum vulgaris showed significant cytotoxicity, which contrasts with previous in-vivo studies. However, they might be considered for investigation as targeted therapeutic agents in the treatment of malignant diseases.
机译:凝集素是能够结合一个或多个特定糖残基的非免疫来源的蛋白质或糖蛋白。在先前的工作中已经描述了使用凝集素作为将药物递送系统定位和“锚定”到粘膜表面上的目标部位以促进受控的药物递送和增强的吸收的手段的潜力。许多凝集素都具有明显的毒性,这项研究调查了凝集素对角膜和结膜来源细胞的细胞毒性。将来自结膜和角膜的转化细胞系的培养物暴露于凝集素溶液,并通过相对于对照吸收MTT染色的能力来评估这些细胞的生存能力。在本研究中测试的所有凝集素均具有明显的凝集素细胞毒性证据,尤其是在较高浓度和更长的时间(48小时)内。这将对它们在靶向药物输送系统中的潜在用途提出问题。番茄(Lycopersicon esculentum)和螺旋藻(Helix pomatia)的凝集素似乎显示出最小的细胞毒活性,因此被认为是最有前途的。马铃薯和普通小麦的凝集素显示出明显的细胞毒性,这与以前的体内研究形成了鲜明的对比。但是,可以考虑将它们作为恶性疾病治疗中的靶向治疗剂进行研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号